Buradasınız

Anasayfa » Content

Hemodiyaliz Hastasında Metastatik Kalsifikasyon ve Kalsiflaksi

Metastatic Calcification and Calciphylaxis in a Hemodialysis Patient

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2014
DOI: 
10.5262/tndt.2014.1002.16

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
While metastatic calcifications are frequently observed in patients treated with dialysis, calciphylaxis remains as a rare but a life-threatening complication. Calciphylaxis results in tissue ischemia and necrosis and is highly progressive. In this case, we report a rapidly progressing calciphylaxis case as well as pointing to the significance of early diagnosis and treatment and the need for a multidisciplinary approach.
Bookmark/Search this post with
Abstract (Original Language): 
Diyaliz tedavisi gören hastalarda metastatik kalsifikasyon sıklıkla gözlenmekle beraber, kalsiflaksi nadir ve hayatı tehdit eden bir komplikasyondur. Kalsiflaksi doku iskemi ve nekrozu sonucu oldukça hızla ilerler. Bu yazıda, hızlı ilerleyen bir kalsiflaksi olgusunun erken tanı ve multidisipliner yaklaşımla tedavisini sunduk.
FULL TEXT (PDF): 
PDF icon arastirmax-hemodiyaliz-hastasinda-metastatik-kalsifikasyon-kalsiflaksi.pdf
  • 2
158
160
  • Turkish

REFERENCES

References: 

1. Weenig RH: Pathogenesis of calciphylaxis: Hans Selye to nuclear
factor kappa-B. J Am Acad Dermatol 2008; 58(3): 458-471
2. Janigan DT, Hirsch DJ, Klassen GA, MacDonald AS: Calcified
subcutaneous arterioles with infarcts of the subcutis and skin
(Calciphylaxis) in chronic renal failure. Am J Kidney Dis 2000;
35(4): 588-597
3. Angelis M, Wong LL, Myers SA, Wong LM: Calciphylaxis in
patients on hemodialysis: A prevalence study. Surgery 1997; 122(6):
1083-1089
4. Mazhar AR, Johnson RJ, Gillen D, Stivelman JC, Ryan MJ, Davis
CL, Stehman-Breen CO: Risk factors and mortality associated with
calciphylaxis in end-stage renal disease. Kidney Int 2001; 60(1):
324-332
5. Block GA: Hyperphosphatemia has been regarded as a risk factor
for calciphylaxis. Clin Nephrol 2000; 54(4): 318-324
6. Wilmer WA, Magro CM: Calciphylaxis: Emerging concepts in
prevention, diagnosis, and treatment. Semin Dial 2002; 15(3): 172-
186
7. Goel SK, Bellovich K, McCullough PA: Treatment of severe
metastatic calcification and calciphylaxis in dialysis patients. Int J
Nephrol 2011; 2011: 701603
8. Fine A, Fontaine B: Calciphylaxis: the beginning of the end? Perit
Dial Int 2008; 28(3): 268-270
9. Angelis M, Wong LL, Myers DPH, Wong LM: Calciphylaxis in
patients on haemodialysis: A prevalence study. Surgery 1997;
122(6): 1083-1089
10. Hahler B: Calciphylaxis in the patient with chronic renal failure.
Dermatol Nurs 2001; 13(6): 435-436, 449

Thank you for copying data from http://www.arastirmax.com